Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18165633 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine
Condition: Non Small Cell Lung Cancer
Interventions: Drug: ZD6474, Vandetanib;   Drug: Placebo to Match ZD6474, Vandetanib;   Drug: Gemcitabine

Indicates status has not been verified in more than two years